Psyence Biomedical Ltd. Common Shares Cash Flow Quality Index
Psyence Biomedical Ltd. Common Shares cash flow quality index. Psyence Biomedical Ltd. Common Shares (PBM) has a Cash Flow Quality Index of -0.04x as of December 2022. Operating cash flow of $-86.26K is below net income of $2.25 Million, suggesting accrual-heavy earnings not yet converted to cash. See Psyence Biomedical Ltd. Common Shares (PBM) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Psyence Biomedical Ltd. Common Shares (2025–2025)
Cash flow quality index of Psyence Biomedical Ltd. Common Shares from 2025 to 2025. Historical Cash Flow Quality Index for Psyence Biomedical Ltd. Common Shares across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PBM cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Psyence Biomedical Ltd. Common Shares Cash Flow Quality Index by Year (2025–2025)
Psyence Biomedical Ltd. Common Shares cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Psyence Biomedical Ltd. Common Shares. For the full cash flow conversion analysis, see Psyence Biomedical Ltd. Common Shares (PBM) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -3.69x | $-3.73 Million | $1.01 Million | — |